Sattva S. Neelapu, MD¹, Caron A Jacobson, MD, MMSc², Armin Ghobadi, MD³, David B. Miklos, MD, PhD⁴, Lazaros J. Lekakis^5*, Clare Spooner, BSc, MBBS^6*, Jenny J. Kim, MD, MS⁷, Harry Miao, MD, PhD⁶, Allen Xiaodong Xue, PhD^6*, Yan Zheng, MD, PhD, MS^6* and Frederick L. Locke, MD⁸

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Dana-Farber Cancer Institute, Boston, MA
³Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁴Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
⁵Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
⁶Kite, a Gilead Company, Santa Monica, CA
⁷Kite Pharma, a Gilead Company, Santa Monica, CA
⁸Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Emmanuel Bachy, MD, PhD^1*, Sattva S. Neelapu, MD², Julio C. Chavez, MD^3*, Ibrahim Yakoub-Agha, MD, PhD^4*, Christine Lui, MS^5*, Jacob Wulff, DrPH^5*, Harry Miao, MD, PhD⁵, Olga Nikolajeva, MD^5*, Timothy Best, PhD^5*, Camille Linot, PharmD, PhD^5* and Caron A Jacobson, MD, MMSc⁶

¹Lyon-Sud Hospital Center, Pierre-Bénite, France
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Malignant Hematology, University of South Florida/Moffitt Cancer Center, Tampa, FL
⁴CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
⁵Kite, a Gilead Company, Santa Monica, CA
⁶Dana-Farber Cancer Institute, Boston, MA

M Hasib Sidiqi^1,2*, Paolo Corradini, MD³, Duncan Purtill, MBBS, FRACP, FRCPA^4*, Hermann Einsele, MD, PhD^5*, Binod Dhakal, MBBS⁶, Lionel Karlin^7*, Salomon Manier^8*, Shinsuke Iida⁹, Sebastian Giebel^10*, Simon J. Harrison, MBBS, MRCP, FRCPath, FRACP, PhD^11,12,13, Brea Lipe, MD¹⁴, Abdullah Khan¹⁵, Jordan M. Schecter¹⁶, Carolyn Chang Jackson¹⁶, Tzu-min Yeh^16*, Arnob Banerjee^17*, William Deraedt^18*, Nikoletta Lendvai^16*, Carolina Lonardi^19*, Ana Slaughter^20*, Katherine Li^17*, Diana Chen^21*, Jane Gilbert^22*, Tito Roccia^23*, Man Zhao^24*, Nitin Patel^25*, Erika Florendo^26*, Mythili Koneru, MD^25*, Octavio Costa Filho^25*, Dong Geng^25*, Jesus San Miguel^27* and Kwee Yong²⁸

¹Fiona Stanley Hospital, Perth, Western Australia, Australia
²Curtin Medical School, Curtin University, Bentley Western Australia, Australia
³University of Milan, Milan, Italy
⁴Haematology Department, Fiona Stanley Hospital, Perth, Western Australia, Australia
⁵Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
⁶Medical College of Wisconsin, Milwaukee, WI
⁷Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁸University of Lille, Lille, France
⁹Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan
¹⁰Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
¹¹Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia
¹²Peter MacCallum Cancer Centre, Melbourne, Australia
¹³Royal Melbourne Hospital, Melbourne, Australia
¹⁴University of Rochester Medical Center, Rochester, NY
¹⁵The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹⁶Janssen Research & Development, Raritan, NJ
¹⁷Janssen Research & Development, Spring House, PA
¹⁸Janssen Research & Development, Beerse, Belgium
¹⁹Janssen, Buenos Aires, ARG
²⁰Cilag GmbH International, Zug, Switzerland
²¹Janssen Research & Development, Shanghai, China
²²Janssen Research & Development, High Wycombe, United Kingdom
²³Janssen Global Services, Raritan, NJ
²⁴IQVIA, Shanghai, China
²⁵Legend Biotech USA Inc., Somerset, NJ
²⁶Legend Biotech USA Inc., Piscataway, NJ
²⁷Cancer Center Clinica Universidad Navarra, Pamplona, Spain
²⁸University College London, London, United Kingdom

Christian R. Schultze-Florey, MD^1*, Christophe Peczynski, MSc^2*, William Boreland^2*, Michael Daskalakis, MD^3*, Anne Sirvent, MD^4*, Ibrahim Yakoub-Agha, MD, PhD^5*, Maria-Luisa Schubert, MD^6*, Christof Scheid, MD^7*, Anne Huynh, MD^8*, Victoria Potter^9*, Didier Blaise^10*, Matthew P. Collin Sr., MD, PhD¹¹, Rafael Hernani^12*, Gerald G. Wulf, MD^13*, Francis A. Ayuk, MD^14*, Caroline Besley, MD^15*, Lucia Lopez Corral, PhD, MD^16*, Edouard Forcade, MD, PhD^17*, Peter Vandenberghe, MD, PhD¹⁸, Dominik Schneidawind, MD, PhD^19*, Matthias Stelljes, MD²⁰, Friedrich Stölzel, MD^21*, Bertram Glass, MD, PhD^22*, Ivan Sergeevich Moiseev, MD^23*, Helene Schoemans, MD^24*, Olaf Penack, MD^25*, Christian Koenecke, MD²⁶ and Zinaida Peric, MD, PhD^27*

¹Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
²EBMT Paris study office / CEREST-TC, Hôpital Saint Antoine, Sorbonne University, Paris, France
³University Hospital Bern, Inselspital, Bern, Switzerland
⁴CHU Montpellier, Montpellier, France
⁵CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
⁶University of Heidelberg, Heidelberg, Heidelberg, DEU
⁷Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany, Cologne, Germany
⁸Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
⁹Department of Haematological Medicine, King's College Hospital NHS, London, United Kingdom
¹⁰Programme de Transplantation & Thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Marseille, France
¹¹Northern Centre for Bone Marrow Transplantation, Newcastle University, Newcastle Upon Tyne, GBR
¹²Clinical Univesity Hospital of Valencia, Valencia, Spain
¹³Universitaetsklinikum Goettingen, Goettingen, Germany
¹⁴Department of Stem Cell Transplantation with Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁵Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
¹⁶Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Hospital Universitario de Salamanca, SALAMANCA, Spain
¹⁷Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hopital Haut-Leveque, Pessac, France
¹⁸Department of Hematology, Department of Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium
¹⁹Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland
²⁰Department of Internal Medicine A, University of Muenster, Muenster, Germany
²¹Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
²²Klinik für Hämatologie und Zelltherapie, Helios Klinik Berlin-Buch, Berlin, Germany
²³RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
²⁴Department of Hematology,Department of Public Health and Primary Care, ACCENT VV, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium
²⁵Department of Hematology, Oncology, and Cancer Immunology, Charité Universitätsmedizin Berlin, Campus Virchow Klinik, Berlin, Germany
²⁶Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, NDS, Germany
²⁷Department of Hematology, University Hospital Centre Zagreb, Zagreb, Croatia

Sattva S. Neelapu, MD¹, Julio C. Chavez, MD², Alison R Sehgal, MD³, Narendranath Epperla, MD, MS⁴, Matthew L. Ulrickson, MD⁵, Emmanuel Bachy, MD, PhD^6*, Pashna N. Munshi, MD⁷, Carla Casulo, MD⁸, David G Maloney, MD, PhD⁹, Sven de Vos, MD, PhD^10*, Ran Reshef, MD, MSc¹¹, Lori A. Leslie, MD¹², Olalekan O. Oluwole, MBBS¹³, Ibrahim Yakoub-Agha, MD, PhD^14*, Rashmi Khanal, MD, MBBS¹⁵, Joseph D. Rosenblatt, MD^16*, Weixin Peng, MS^17*, Christine Lui, MS^17*, Jacob Wulff, DrPH^17*, Rhine R. Shen, PhD^17*, Soumya Poddar, PhD^17*, Andrew Lee, MD^17*, Harry Miao, MD, PhD¹⁷, Olga Nikolajeva, MD^17* and Caron A Jacobson, MD, MMSc¹⁸

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Moffitt Cancer Center, Tampa, FL
³UPMC Hillman Cancer Center, Pittsburgh, PA
⁴The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
⁵Banner MD Anderson Cancer Center, Gilbert, AZ
⁶Lyon-Sud Hospital Center, Pierre-Bénite, France
⁷Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
⁸Wilmot Cancer Center, University of Rochester, Rochester, NY
⁹Fred Hutchinson Cancer Center, Seattle, WA
¹⁰Ronald Reagan University of California Los Angeles Medical Center, Santa Monica
¹¹Columbia University Irving Medical Center, New York
¹²Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
¹³Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
¹⁴CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, LILLE, FRA
¹⁵Fox Chase Cancer Center, Philadelphia, PA
¹⁶University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
¹⁷Kite, a Gilead Company, Santa Monica, CA
¹⁸Dana-Farber Cancer Institute, Boston, MA

John G. Gribben, MD, DSc¹, Paola Ghione, MD, MSEpi^2,3, Maria Lia Palomba, MD⁴, Markqayne D Ray, PharmD^5*, Eve H Limbrick-Oldfield^6*, Steve Kanters, PhD^6*, Sabela Bobillo, MD, PhD^7*, Maria Teresa Ribiero^8*, Caron A Jacobson, MD, MMSc⁹, Sattva S. Neelapu, MD¹⁰, Herve Ghesquieres, MD, PhD^11*, Olga Nikolajeva, MD^12*, Jiali Yan, MS^12*, Hailin Wang^12* and Anik R Patel, PhD^5*

¹Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
²Memorial Sloan Kettering Cancer Center, New York, NY
³Roswell Park Comprehensive Cancer Center, New York, NY
⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁵Kite, A Gilead Company, Santa Monica, CA
⁶RainCity Analytics, Vancouver, BC, Canada
⁷Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁸Portuguese Oncology Institute of Porto, Porto, Portugal
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Centre Hospitalier Lyon Sud, Lyon, France
¹²Kite, a Gilead Company, Santa Monica, CA

Mariana Bastos-Oreiro, MD^1*, Pau Abrisqueta Costa^2*, Antonio Gutierrez^3*, Ana Jimenez Ubieto^4*, Maria Pozas, MD^5*, Sonia Gonzalez De Villambrosia, MD^6*, Raul Cordoba, MD, PhD⁷, Alberto Lopez Garcia, MD⁷, Elena Perez Ceballos^8*, Belen Navarro^9*, Ana Muntanola, MD PhD^10*, Eva Donato, MD PhD^11*, Eva Diez-baeza^12*, Maria Lourdes Escoda Teigell^13*, Hugo Daniel Luzardo Henriquez, MD^14*, María Peñarrubia-Ponce^15*, Daniel Garcia Belmonte, MD^16*, Emilia Pardal^17*, Claudia Lozada^18*, Armando Lopez-Guillermo, MD PhD¹⁹ and Alejandro Martín García-Sancho^20*

¹Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
²Vall d'Hebron University Hospital, Barcelona, Spain
³Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
⁴Hospital Universitario 12 de Octubre, MADRID, MADRID, Spain
⁵Hospital Universitario 12 de Octubre, Madrid, Spain
⁶IDIVAL/Valdecilla, Santander, Spain
⁷Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁸Hospotal Morales Meseguer, Murcia, ESP
⁹Hospital Puerta De Hierro, Madrid, ESP
¹⁰Hematology Department, Hospital Universitario Mutua de Terrassa, Terrassa, AL, ESP
¹¹Hematology Department, Hospita Universitario Doctor Peset, Valencia, ESP
¹²Hospital Clínico Universitario de Salamanca, MD, Madrid, Spain
¹³Hospital Juan XXXIII, Instituto Catalán de la Salud, Tarragona, ESP
¹⁴Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
¹⁵Hospital ClíNico Universitario De Valladolid, Valladolid, ESP
¹⁶Hematology Department, Hospital Universitario La Zarzuela, Madrid, Spain
¹⁷Hospital Virgen Del Puerto, Plasencia, ESP
¹⁸Instituto Valenciano de Oncología, Valencia, 46009, Spain
¹⁹Hospital Clínic de Barcelona, Barcelona, Spain
²⁰Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain

Zhonghui Jiang^1*, Zhiping Fan^2*, Hui Xu^3*, Na Xu^4*, Tian Zhang^3*, Huiwen Xue^5*, Ren Lin^2*, Zhixiang Wang^5*, Ling Jiang^5*, Jing Sun, Mphil, BEng^6,7* and Li Xuan^4*

¹Department of Hematology, Nanfang Hospital, Southern Medical University, Guang Zhou, China
²Nanfang Hospital, Southern Medical University, Guangzhou, China
³Nanfang Hospital, Southern Medical University, Guang Zhou, China
⁴Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
⁵Nanfang Hospital, Southern Medical University, Guangzhou, CHN
⁶Nanfang hospital of southern medical university, guangzhou, China
⁷Nanfang hospital of southern medical university, London, ENG, United Kingdom

Rakesh Awasthi, PhD^1*, Edward Waldron, PhD^2*, Stephan Grupp, MD, PhD^3,4, Michael A. Pulsipher, MD⁵, Peter Bader, MD, PhD⁶, Stephen J Schuster, MD^7*, Richard T Maziarz, MD⁸, Edmund K. Waller, MD⁹, Ulrich Jaeger, MD^10*, Catherine Thieblemont, MD^11*, Martin Dreyling, MD¹², Nathan Fowler, MD^13,14, Harald Jakob Maier, MD^15* and Jennifer Willert, MD^2*

¹Novartis Institutes for BioMedical Research, Parsippany, NJ
²Novartis Pharmaceuticals Corporation, East Hanover, NJ
³Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
⁴Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia
⁵Division of Hematology and Oncology, Intermountain Primary Children’s Hospital, Huntsman Cancer Institute, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, UT
⁶Department of Pediatrics, Division for Stem Cell Transplantation, Immunology and Intensive Care, Goethe University Frankfurt, University Hospital, Frankfurt, Germany
⁷Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁸Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁹Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
¹⁰Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
¹¹Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Université de Paris, Paris, France
¹²Medizinische Klinik III, Klinikum der Universität, LMU München, Munich, Germany
¹³The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴BostonGene, Corp., Waltham, MA
¹⁵Novartis Pharma AG, Basel, Switzerland

Cristiana Carniti^1*, Martina Magni^1*, Nicole Caldarelli^2*, Tommaso Torelli^3*, Luca Agnelli^3*, Eugenio Fardella, MD^4*, Daniele Lorenzini^5*, Arianna Rigamonti^4*, Sadhana Jonnalagadda^4*, Giada Zanirato^1*, Anisa Bermema^1*, Silvia Brich^5*, Anna Dodero^1*, Annalisa Chiappella, MD⁶ and Paolo Corradini, MD⁴

¹Hematology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
²Fondazione IRCCS Istituto Nazionale Tumori, Hematology, University of Milan, Milano, Italy
³Department of Advanced Diagnostic Innovations, IRCCS Istituto Nazionale Tumori, Milano, Italy
⁴University of Milan and Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
⁵Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
⁶Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Milano, Italy

Upendra Mahat, mbbs^1*, Pamela Seam, MD^2*, Najat Bouchkouj, MD^3*, Poornima Sharma, MD^3*, Helka Peredo-Pinto, MD, MPH^3*, Mona Elmacken, MD^3*, Megha Kaushal, MD^3*, Shu Wang, PhD^4*, Zhiheng Xu, PhD^4*, Yuxia Jia, MD^5*, Nicholas Richardson, DO, MPH², Bindu Kanapuru, MD^2*, Yvette Kasamon, MD² and Nicole Gormley, MD²

¹Division of Clinical Evaluation Hematology, Office of Therapeutic Products (OTP), Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Dunkirk, MD
²Division of Hematologic Malignancies II, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD
³Division of Clinical Evaluation Hematology, Office of Therapeutic Products (OTP), Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Silver Spring, MD
⁴Office of Biostatistics, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD
⁵Division of Clinical Evaluation Oncology, Office of Therapeutic Products (OTP), Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Silver Spring, MD

Valentin Ortiz-Maldonado, MD^1*, Nuria Martinez-Cibrian, MD^2*, Gonzalo Del Campo Balguerías, MD^3*, Marta Español-Rego, MD, PhD^4*, Sergio Navarro, Biochem^4*, Helena Brillembourg, MD^5*, Leticia Alserawan, Phar^6*, Maria Castella, PhD^6*, Daniel Benitez-Ribas, PhD^7*, Laura Magnano, MD, PhD^5*, Juan Gonzalo Correa, MD^8*, Andrea Rivero, MD^9*, Pablo Mozas, MD, PhD^10*, Aina Oliver Caldes, MD^11*, Eva Gine, MD¹², Luis Gerardo Rodríguez-Lobato, MD, PhD^9*, Alexandra Martínez-Roca, MD^2*, Mercedes Montoro-Lorite, RN^10*, Pilar Ayora, RN^5*, Carlos Fernández de Larrea^13*, Mariona Pascal, PhD^6*, Jordi Esteve Reyner, MD, PhD^5*, Alvaro Urbano-Ispizua Sr., MD⁵, Manel Juan, MD, PhD^14* and Julio Delgado^2*

¹Hospital Clinic, Barcelona, Spain
²Hospital Clínic de Barcelona, Barcelona, Spain
³Department of Hematology, Hospital Clínico San Carlos, Madrid, Spain
⁴Department of Immunology, Hospital Clínic, Barcelona, Spain
⁵Department of Hematology, Hospital Clínic, Barcelona, Barcelona, Spain
⁶Department of Immunology, Hospital Clínic, Barcelona, Barcelona, Spain
⁷Department of Immunology, Hospital Clínic, Barcelona, Barcelona, ESP
⁸Department of Hematology, Hospital Clínic, Barcelona, Spain
⁹Department of Hematology, Hospital Clínic, Barcelona, ESP
¹⁰Department of Hematology, Hospital Clínic, Barcelona, Barcelona, ESP
¹¹Department of Hematology. Hospital Clinic de Barcelona. IDIBAPS. Universidad de Barcelona., Barcelona, Spain
¹²Hospital Clinic of Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
¹³Department of Haematology, Hospital Clínic, Barcelona, Spain
¹⁴Department of Immunology, Platform of Immunotherapy Clínic-Sant Joan de Déu, Hospital Clínic, Barcelona, Spain

Saurabh Dahiya^1*, Jay Y. Spiegel, MD, FRCPC², Dasom Lee, MD^3*, Turab Mohammed, MD^4*, Forat Lutfi, MD⁵, Anmol Goyal, MD^6*, Caroline Hana^7*, Julio C Chavez, MD⁸, Filip Ionescu, MD⁹, Matthew J. Frank, MD, PhD¹, Sushma Bharadwaj, MD, MS¹⁰, Jose Sandoval-Sus, MD¹¹, Amer M. Beitinjaneh, MD, MS^12*, Lazaros J. Lekakis^13*, Joseph P McGuirk, DO⁵, Frederick L. Locke, MD¹⁴, David B. Miklos, MD, PhD¹ and Michael D. Jain, MD, PhD¹⁴

¹Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
²Miller School of Medicine, University of Miami, Miami, FL
³Division of Hematology, Stanford University, Stanford
⁴Moffit Cancer Center, Tampa, FL
⁵University of Kansas Medical Center, Westwood, KS
⁶Stanford University, Palo Alto, CA
⁷Memorial Hospital/Moffitt, Pembroke Pines, FL
⁸Department of Malignant Hematology, Moffitt Cancer Center, Lutz, FL
⁹USF/ Moffitt Cancer Center, Tampa, FL
¹⁰Stanford, Palo Alto, CA
¹¹H Lee Moffitt Cancer Center at Memorial Cancer Institute, Ft Lauderdale, FL
¹²Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FL
¹³Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
¹⁴Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Ibrahim Aldoss, MD¹, Gregory W Roloff, MD², Anjali S. Advani, MD³, Noam E. Kopmar, MD⁴, Chenyu Lin, MD⁵, Simone E. Dekker, MD, PhD⁶, Vishal K Gupta, MD⁷, Nikeshan Jeyakumar, MD^8*, Timothy E O'Connor, MD⁹, Amy Zhang, PhD^10*, Katharine Miller, PhD, MPH^10*, Kaitlyn C Dykes, MD^11*, Mohamed Ahmed¹², Hector Zambrano^13*, Danielle Bradshaw, MD^14*, Santiago Mercadal, MD^15*, Marc Schwartz, MD^16*, Sean Tracy, MD, PhD¹⁷, Bhagirathbhai Dholaria, MBBS¹⁸, Michal Kubiak, MD¹⁴, Akash Mukherjee, MD^19*, Navneet Majhail, MD, MS, FASTCT²⁰, Minoo Battiwalla, MD²¹, Luke Mountjoy, DO²², Shahbaz A. Malik, MD²³, John Mathews, MD^24*, Paul Shaughnessy, MD²⁵, Aaron C. Logan, MD, PhD²⁶, Abdullah Ladha, MD^27*, George Yaghmour, MD²⁸, Maryann Stefan^3*, Caitlin Guzowski, MBA^29*, Rasmus T. Hoeg, MD^30*, Talal Hilal, MD³¹, Jozal Moore, MD³², Kristen M. O'Dwyer, MD³², Stephanie B. Tsai, MD, MS⁹, Joshua Sasine, MD¹², Melhem M. Solh, MD²⁹, Catherine J. Lee, MD³³, Vamsi K. Kota, MD³⁴, Divya Koura, MD¹¹, Muthu Veeraputhiran, MD^19*, Betsy Blunk^13*, Jessica T. Leonard, MD³⁵, Caspian H. Oliai, MD⁷, Veronika Bachanova, MD, PhD¹⁷, Wendy Stock, MD², Ahmed Galal, MD⁵, Vinod Pullarkat, MD³⁶, Ryan D Cassaday, MD⁴, Bijal D. Shah, MD³⁷, Rawan Faramand, MD³⁸ and Lori S. Muffly, MD⁸

¹City of Hope, Duarte, CA
²University of Chicago, Chicago, IL
³Cleveland Clinic Foundation, Cleveland, OH
⁴University of Washington, Seattle, WA
⁵Duke University School of Medicine, Durham, NC
⁶Department of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR
⁷University of California Los Angeles, Los Angeles, CA
⁸Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁹Loyola University, Maywood, IL
¹⁰Stanford University School of Medicine, Stanford, CA
¹¹University of California San Diego, La Jolla, CA
¹²Cedars-Sinai Medical Center, Los Angeles, CA
¹³Sarah Cannon Research Institute, Nashville, TN
¹⁴Augusta University, Augusta, GA
¹⁵University of Utah, Salt Lake City, UT
¹⁶Division of Hematology, University of Colorado, Aurora, CO
¹⁷University of Minnesota, Minneapolis, MN
¹⁸Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
¹⁹University of Arkansas for Medical Sciences, Little Rock, AR
²⁰Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN
²¹Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN
²²Colorado Blood Cancer Institute and Sarah Cannon Cancer Institute at Presbyterian/St Luke’s Medical Center, Denver, CO
²³St. David's South Austin Medical Center, Austin, TX
²⁴Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX
²⁵Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX
²⁶Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
²⁷University of Southern California, Los Angeles, CA
²⁸Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
²⁹Northside Hospital, Atlanta, GA
³⁰Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis, Sacramento, CA
³¹Mayo Clinic, Phoenix, AZ
³²University of Rochester, Rochester, NY
³³Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
³⁴Georgia Cancer Center, Augusta University, Augusta, GA
³⁵Oregon Health & Science University, Portland, OR
³⁶Hematology/HCT, City of Hope National Medical Center, Duarte, CA
³⁷Moffitt Cancer Center and Research Institute, Tampa, FL
³⁸Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Sushma Bharadwaj, MD, MS¹, Eric Lau, DO², Anmol Goyal, MD^3*, Mark P. Hamilton, MD⁴, Hrishikesh Srinagesh^5*, Alexandria Jensen, PhD^6*, Shriya Syal, MS^7*, Jayasindhu Mallampet^8*, Theresa Latchford^9*, Bita Sahaf, PhD, MSc^7*, Wen-Kai Weng, MD, PhD⁸, Melody Smith, MD, MS¹⁰, Holden T Maecker, PhD^11*, Matthew J. Frank, MD, PhD⁸, David B. Miklos, MD, PhD⁸ and Saurabh Dahiya^8*

¹Stanford, Palo Alto, CA
²Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Mountain View, CA
³Stanford University, Palo Alto, CA
⁴Division of Hematology and Oncology, Stanford University, Palo Alto, CA
⁵Stanford University, Stanford
⁶Quantitative Sciences Unit, Stanford University, Palo Alto, CA
⁷Cancer Correlative Science Unit, Stanford University, Palo Alto, CA
⁸Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
⁹Stanford Health Care, Stanford, CA
¹⁰Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA
¹¹Stanford University, Stanford, CA

Rachid Baz, MD¹, Paula Rodriguez Otero, MD, PhD^2*, Sikander Ailawadhi³, Bertrand Arnulf, MD, PhD⁴, Krina K. Patel, MD, MSc⁵, Ajay K. Nooka, MD, MPH⁶, Luciano Costa, MD, PhD⁷, Noopur S. Raje^8*, Ingerid Weum Abrahamsen, MD, PhD^9*, Michel Delforge^10*, Usama Gergis, MD, MBA^11*, Douglas W. Sborov, MD, MSc¹², Sergio A. Giralt, MD, FACP¹³, Marc S. Raab^14*, Tadao Ishida¹⁵, Asya Varshavsky-Yanovsky^16*, Taewoong Choi^17*, Larry D. Anderson Jr., MD, PhD¹⁸, Anna Truppel-Hartmann, MD^19*, Rashmi Bhatnagar^20*, Fan Wu^21*, Julia Piasecki^21*, Jasper Felten^21*, Andrea Caia^21*, Mark Cook, MBChB, PhD²² and Yi Lin, MD, PhD²³

¹H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Clinica Universidad de Navarra, Pamplona, Spain
³Mayo Clinic, Jacksonville, FL
⁴Hôpital Saint-Louis, APHP, Université Paris cite, Paris, France
⁵MD Anderson Cancer Center, University of Texas, Houston, TX
⁶Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁷University of Alabama at Birmingham, Birmingham, AL
⁸Massachusetts General Hospital, Boston, MA
⁹Oslo University Hospital, Oslo, Norway
¹⁰Universitaire Ziekenhuizen Leuven, Leuven, Belgium
¹¹Thomas Jefferson University, Philadelphia, PA
¹²Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
¹³Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Heidelberg University Hospital, Heidelberg, Germany
¹⁵Japanese Red Cross Medical Center, Tokyo, Japan
¹⁶Fox Chase Cancer Center, Philadelphia, PA
¹⁷Duke University Medical Center, Durham, NC
¹⁸Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
¹⁹2seventy bio, Cambridge, MA
²⁰Syneos Health, Haryana, India
²¹Bristol Myers Squibb, Princeton, NJ
²²Bristol Myers Squibb, Boudry, Switzerland
²³Mayo Clinic Cancer Center, Rochester, MN

Charlotte B Wagner, PharmD^1*, Karen Sweiss, PharmD², Eric Anto, M.S.^1*, Rebecca Gonzalez, PharmD^3*, Omar Alexis Castaneda Puglianini, MD⁴, Ciara Louise L. Freeman, MD, PhD, MSc⁵, Filip Ionescu, MD⁶, Krina K. Patel, MD, MSc⁷, Christopher Ferreri, MD^8*, Mahmoud Gaballa, MD⁹, Leyla Shune, MD¹⁰, Joseph P McGuirk, DO¹¹, Surbhi Sidana, MD¹², Vanna Hovanky, MS^12*, Jack Khouri, MD¹³, Danai Dima, MD¹⁴, Hamza Hashmi, MD^15*, James A Davis, PharmD^16*, Aimaz Afrough, MD¹⁷, Gurbakhash Kaur, MD, MA¹⁸, Larry D. Anderson Jr., MD, PhD¹⁹, Peter A. Forsberg, MD^20*, Megan Herr, PhD²¹, Doris K. Hansen, MD²², Douglas Sborov, MD, MS¹ and Mehmet H. Kocoglu, MD²³

¹Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
²Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
³Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Department of Blood and Marrow Transplant & Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶USF/ Moffitt Cancer Center, Tampa, FL
⁷University of Texas MD Anderson Cancer Center, Houston, TX
⁸The University of Texas MD Anderson Cancer Center, Houston
⁹Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰University of Kansas Medical Center, Kansas City, KS
¹¹University of Kansas Medical Center, Westwood, KS
¹²Stanford University, Stanford, CA
¹³Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹⁴Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹⁵Medical University of South Carolina, Charleston, SC
¹⁶Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
¹⁷Hematologic Malignancies and Cellular Therapy, University of Texas Southwestern Medical Center, Dallas, TX
¹⁸Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
¹⁹Hematologic Malignancies and Cellular Therapy, UT Southwestern Medical Center, Dallas, TX
²⁰Division of Hematology, University of Colorado Health Blood Disorders and Cell Therapies Center, Aurora, CO
²¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
²³University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD

Mattéo Mauget^1,2*, Guillaume Manson^2* and Roch Houot, MD, PhD^3,4,5*

¹Intensive Care Unit, CHU Rennes, Rennes, France
²Hematology Department, CHU Rennes, Rennes, France
³Centre Hospitalier Universitaire Rennes, Université de Rennes, Rennes Cedex, FRA
⁴CHU de Rennes, Rennes, France
⁵Clinical Hematology, INSERM U1236, EFS, Hopital Pontchaillou, Rennes University Hospital, Rennes, France

Danai Dima, MD^1,2, James A Davis, PharmD^2,3*, Aliya Rashid, DO, MPH^2,4, Mikhaila Rice, PharmD^5*, Shaun DeJarnette^4*, Leyla Shune, MD^2,4, Jack Khouri, MD¹, Shahzad Raza, MD^1*, Joseph P McGuirk, DO^2,4, Faiz Anwer, MD^1,2, Nausheen Ahmed, MD^2,4, Al-Ola Abdallah, MD^2,4 and Hamza Hashmi, MD^2,3*

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Department of Hematology-Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁴Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁵Department of Pharmacy, Cleveland Clinic, Cleveland, OH

Rebeca Bailen^1*, Mi Kwon², Gloria Iacoboni, MD^3*, Juan Luis Reguera, MD^4*, Lucia Lopez Corral, MD, PhD^5*, Rafael Hernani^6*, Valentin Ortiz-Maldonado, MD^7*, Manuel Guerreiro, MD^8*, Ana Carolina Caballero Gonzalez^9*, Luisa Guerra^10*, Jose Maria Sanchez Pina^11*, Alberto Mussetti, MD^12*, Juan-Manuel Sancho, MD, PhD^13*, Mariana Bastos-Oreiro^14*, Eva Catalá, MD^1*, Javier Delgado Serrano^15*, Hugo Daniel Luzardo Henriquez, MD^16*, Jaime Sanz Caballer, MD, PhD^17*, Maria Calbacho^18*, Cecilia Carpio^19*, Josep-Maria Ribera, MD, PhD²⁰, Anna Torrent^21*, Anna Maria Sureda Balari, MD, PhD²², Javier Briones, MD^23*, Juan Carlos Hernandez Boluda, MD, PhD^24*, Nuria Martinez-Cibrian, MD^25*, Alejandro Martin Garcia-Sancho, MD^26* and Pere Barba, MD²⁷

¹Department of Hematology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, ESP
²Department of Hematology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
³Hospital Universitari Vall d’Hebron-Universitat Autónoma de Barcelona, SEATTLE, WA
⁴Department of Hematology, University Hospital Virgen del Rocio-IBIS. Universidad de Sevilla., Sevilla, Spain
⁵Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), SALAMANCA, ESP
⁶Hospital Clínico Universitario, Valencia, Spain
⁷Hospital Clinic de Barcelona, IDIBAPS., Barcelona, Spain
⁸Hospital Universitario La Fe, Valencia, Spain
⁹Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
¹⁰Sevicio de Hematología, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain
¹¹Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
¹²Institut Catala d’Oncologia-Hospitalet, Clinical Hematology Department, Barcelona, Spain
¹³Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Barcelona, Spain
¹⁴Hospital General Universitario Gregorio Marañón, Madrid, Spain
¹⁵Department of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, ESP
¹⁶Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
¹⁷Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Valencia, ESP
¹⁸Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁹University Hospital Vall d’Hebron, Barcelona, Spain
²⁰ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain
²¹Institut Català D'oncologia-Hospital Germans Trias I Pujol. Josep Carrera, Badalona, ESP
²²Clinical Hematology Department, Institut Català d’Oncologia, Hospital Duran i Reynals, IDIBELL, Univerisitat de Barcelona, Barceloma, Spain
²³Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, Barcelona, Spain
²⁴Hospital Clínico Universitario-INCLIVA, Valencia, Spain
²⁵Department of Hematology, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
²⁶Department of Hematology, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
²⁷Deparment of Hematology, Vall Hebron Institute of Oncology (VHIO), Hospital Universitari Vall D'Hebron, La Garriga, Barcelona, Spain

Filip Ionescu, MD¹, Bijal D. Shah, MD², Meghan Menges^3*, Kayla Reid, MS^4*, Hanna Bailey, PharmD^5*, Elizabeth DiMaggio^5*, Rebecca Gonzalez, PharmD^6*, Christina A Bachmeier, PharmD^3*, Salvatore Corallo^7*, Luis Cuadrado Delgado^5*, Turab Mohammed, MD^8*, Taiga Nishihori, MD⁷, Farhad Khimani, MBBS^7*, Aleksandr Lazaryan, MD, PhD, MPH⁷, Hien Liu, MD³, Marco Davila, MD, PhD⁹, Fabiana Perna, MD, PhD⁷, Julio C Chavez, MD², Frederick L. Locke, MD⁷ and Michael D. Jain, MD, PhD⁷

¹USF/ Moffitt Cancer Center, Tampa, FL
²Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
³Moffitt Cancer Center, Tampa, FL
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Moffitt Cancer Center, Tampa
⁶Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁸Moffit Cancer Center, Tampa, FL
⁹Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Danai Dima, MD^1,2, Aliya Rashid, DO, MPH^2,3, James A Davis, PharmD^2,4*, Hussein Awada^1*, Al-Ola Abdallah, MD^2,3, Hong Li, MS^5*, Shaun DeJarnette^3*, Leyla Shune, MD^2,3, Jack Khouri, MD¹, Hamza Hashmi, MD^2,4*, Joseph P McGuirk, DO^2,3, Faiz Anwer, MD^1,2 and Nausheen Ahmed, MD^2,3

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁴Department of Hematology-Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁵Department of Biostatistics and Quantitative Health Sciences, Cleveland Clinic, Cleveland

Gil Fridberg^1*, Odelia Amit, MD^1*, Liat Shargian, MD^2*, Ofrat Beyar Katz³, Sigal Grisariu, MD^4*, Chava Perry, MD^1*, Ronit Gurion, MD^5*, Batia Avni, MD^4*, Tsila Zuckerman^3*, Irit Avivi Mazza, MD^1* and Ron Ram, MD¹

¹BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Hematology Institute, Davidoff Center, Rabin Medical Center, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³Department of Hematology and BMT, Rambam Health Care Campus, Haifa, Israel
⁴Bone Marrow Transplantation & Cancer Immunotherapy Department, Hadassah-Hebrew University Medical Center and Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel
⁵Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel

William Wesson, MPH¹, Forat Lutfi, MD², David L. Porter, MD³, Veronika Bachanova, MD, PhD⁴, Loretta J. Nastoupil, MD⁵, Peter A. Riedell, MD⁶, Miguel-Angel Perales, MD⁷, Richard T Maziarz, MD⁸, Jamie Brower, MS^3*, Gunjan L. Shah⁹, Andy Chen, MD, PhD⁸, Olalekan O. Oluwole, MBBS¹⁰, Stephen J Schuster, MD¹¹, Michael R. Bishop, MD⁶, Joseph P McGuirk, DO¹² and Nausheen Ahmed, MD^2*

¹University of Kansas School of Medicine, Kansas City, KS
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
³Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁴Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
⁵MD Anderson Cancer Center, Houston, TX
⁶David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
⁷Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁹Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
¹¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹²University of Kansas Medical Center, Westwood, KS

Alfredo Rivas-Delgado, MD, PhD¹, Efrat Luttwak, MD², Esther Drill, DrPH^3*, Ilan Goldstein, BS^4*, Ivan Landego, MD^4,5*, Ana Alarcon Tomas, MD^4*, Allison Parascondola, MPH^4*, Amethyst Saldia, BS^4*, Philip Caron, MD², Parastoo B. Dahi, MD^4,5*, Zachary D. Epstein-Peterson, MD², Lorenzo Falchi, MD², Paul A. Hamlin, MD², William Johnson^2,5*, Anita Kumar, MD⁶, Richard J. Lin, MD, PhD^4,5, Jennifer Kimberly Lue, MD², Colette Owens, MD², Ariela Noy, MD², Michael Scordo^4,5, Ahmet Dogan, MD, PhD⁷, Venkatraman Seshan, PhD^3*, Andrew D. Zelenetz, MD, PhD², Miguel-Angel Perales, MD^4,5, Roni Shouval, MD, PhD^4,5, Maria Lia Palomba, MD^2,5, Gunjan L. Shah^4,5 and Gilles Salles, MD, PhD^2,5

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Barcelona, Spain
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY

Efrat Luttwak, MD¹, Jessica R. Flynn, MS^2*, Sean M. Devlin, PhD^3*, Giulio Cassanello^4*, Magdalena Corona, MD^4*, Parastoo B. Dahi, MD^4,5*, Alejandro Luna De Abia, MD, PhD^4*, Joshua Fein, MD^6*, Sergio A. Giralt, MD, FACP⁴, Ivan Landego, MD^4*, Richard J. Lin, MD, PhD⁴, Maria Lia Palomba, MD^7,8, Allison Parascondola, MPH^4*, Jae H. Park, MD⁴, Amethyst Saldia, BS^4*, Michael Scordo⁴, Ana Alarcon Tomas, MD^4*, Gunjan L. Shah^4,8, Miguel-Angel Perales, MD^4,8, Gilles Salles, MD, PhD^7,8 and Roni Shouval, MD, PhD^4,8*

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Weill Cornell Medical College, New York, NY
⁶Department of Hematology & Medical Oncology, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY
⁷Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁸Department of Medicine, Weill Cornell Medical College, New York